<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id><journal-id journal-id-type="publisher-id">KJIM</journal-id><journal-title-group><journal-title>The Korean Journal of Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">1226-3303</issn><issn pub-type="epub">2005-6648</issn><publisher><publisher-name>The Korean Association of Internal Medicine</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22707896</article-id><article-id pub-id-type="pmc">3372808</article-id><article-id pub-id-type="doi">10.3904/kjim.2012.27.2.221</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Aldosterone-Producing Adrenocortical Carcinoma without Hypertension</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Song</surname><given-names>Min Soo</given-names></name><xref ref-type="aff" rid="A1-kjim-27-221"/></contrib><contrib contrib-type="author"><name><surname>Seo</surname><given-names>Sung Woo</given-names></name><xref ref-type="aff" rid="A1-kjim-27-221"/></contrib><contrib contrib-type="author"><name><surname>Bae</surname><given-names>Sang Byung</given-names></name><xref ref-type="aff" rid="A1-kjim-27-221"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kim</surname><given-names>Yeo Joo</given-names></name><xref ref-type="aff" rid="A1-kjim-27-221"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Sang Jin</given-names></name><xref ref-type="aff" rid="A1-kjim-27-221"/></contrib></contrib-group><aff id="A1-kjim-27-221">Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea.</aff><author-notes><corresp>Correspondence to Yeo Joo Kim, M.D. Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, Korea. Tel: 82-41-570-3672, Fax: 82-41-574-5762, <email>yeojoo@schch.co.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>31</day><month>5</month><year>2012</year></pub-date><volume>27</volume><issue>2</issue><fpage>221</fpage><lpage>223</lpage><history><date date-type="received"><day>26</day><month>6</month><year>2008</year></date><date date-type="rev-recd"><day>29</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>31</day><month>8</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#xA9; 2012 The Korean Association of Internal Medicine</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Although adrenocortical tumors are common, adrenocortical carcinomas are rare. Moreover, aldosterone-producing adrenocortical carcinomas without hypertension are exceedingly rare, with only two previously reported cases.</p></abstract><kwd-group><kwd>Aldosterone</kwd><kwd>Carcinoma</kwd><kwd>Hypertension</kwd><kwd>Hyperaldosteronism</kwd></kwd-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Primary aldosteronism is a syndrome characterized by hypertension and hypokalemia [<xref ref-type="bibr" rid="B1-kjim-27-221">1</xref>]. Aldosterone-producing adenomas (APAs) and bilateral idiopathic hyperaldosteronism (IHA) are the most common causes of primary aldosteronism, with APA accounting for approximately 35% of the cases, and IHA accounting for 60% [<xref ref-type="bibr" rid="B2-kjim-27-221">2</xref>]. Aldosterone-producing adrenocortical carcinomas (APACs) are a very rare cause of primary aldosteronism [<xref ref-type="bibr" rid="B3-kjim-27-221">3</xref>]. As a cause of primary aldosteronism, an APAC is characterized by hypertension and hypokalemia [<xref ref-type="bibr" rid="B3-kjim-27-221">3</xref>]; however, very few APACs have features of normotensive primary aldosteronism [<xref ref-type="bibr" rid="B4-kjim-27-221">4</xref>,<xref ref-type="bibr" rid="B5-kjim-27-221">5</xref>]. Here, we report a case of APAC without hypertension.</p></sec><sec><title>CASE REPORT</title><p>A 32-year-old woman was referred to our hospital for evaluation of a left adrenal mass. She had undergone an appendectomy 2 weeks earlier, and the mass was diagnosed incidentally on postoperative abdominal ultrasonography. On admission, her blood pressure was 110/70 mmHg, and her pulse was 80 beats/min. Serial blood pressures during her hospital stay ranged from 110/70 to 130/80 mmHg. The patient had hypokalemia (2.5 mmol/L) and was started on spironolactone (100 mg twice daily) and oral potassium chloride. The plasma aldosterone level was 389.53 pg/mL (normal range, 10.0 to 105) in the supine position and 716.87 pg/mL in the upright position (normal range, 34.0 to 273.0). Plasma rennin activity was 0.1 nmol/L/hr. Computed tomography showed a solid, homogenous adrenal mass with a maximum diameter of 42 mm (<xref ref-type="fig" rid="F1-kjim-27-221">Fig. 1</xref>). An adrenalectomy with lymphadenectomy was performed. The tumor was an ill-defined, gray-tan solid mass measuring 42 &#xD7; 33 &#xD7; 22 mm (<xref ref-type="fig" rid="F2-kjim-27-221">Fig. 2</xref>). Histopathologically, it consisted of a solid nest of bland to anaplastic cells with frequent mitoses and necrosis (<xref ref-type="fig" rid="F2-kjim-27-221">Fig. 2</xref>). Her potassium level normalized on postoperative day 7 without potassium supplements or spironolactone.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In approximately 60% of cases, an adrenocortical carcinoma presents with evidence of adrenal steroid hormone excess [<xref ref-type="bibr" rid="B6-kjim-27-221">6</xref>], while APACs are exceedingly rare. To our knowledge, only 59 cases have been reported, including our case [<xref ref-type="bibr" rid="B3-kjim-27-221">3</xref>]. An apac is usually associated with hypokalemia, renal potassium leakage, and arterial hypertension due to excessive aldosterone secretion. A few specific symptoms such as muscle weakness and cramping, headache, palpitations, polydipsia, polyuria, and nocturia, or a combination of these symptoms, may be present in cases of marked hypokalemia [<xref ref-type="bibr" rid="B7-kjim-27-221">7</xref>]. Patients with suspected primary aldosteronism can be screened by measuring the morning ambulatory paired random plasma aldosterone concentration and plasma renin activity [<xref ref-type="bibr" rid="B2-kjim-27-221">2</xref>]. However, several studies have shown that most patients with primary aldosteronism have baseline blood potassium levels in the normal range [<xref ref-type="bibr" rid="B8-kjim-27-221">8</xref>,<xref ref-type="bibr" rid="B9-kjim-27-221">9</xref>]. Consequently, hypokalemia is not used to establish the diagnosis of primary aldosteronism, and an increased ratio of plasma aldosterone concentration to plasma renin activity is not diagnostic in itself [<xref ref-type="bibr" rid="B2-kjim-27-221">2</xref>]. Primary aldosteronism can be confirmed by an oral sodium loading test, an intravenous saline infusion test, or a fludrocortisone suppression test [<xref ref-type="bibr" rid="B2-kjim-27-221">2</xref>].</p><p>An APAC is a rare cause of primary aldosteronism. Typically, a patient with an APAC has features of primary aldosteronism, including hypertension and hypokalemia. Nevertheless, two of the 58 reported APAC patients had normal blood pressure [<xref ref-type="bibr" rid="B3-kjim-27-221">3</xref>]. The two cases of APAC without hypertension were reported by Muthusethupathi et al. [<xref ref-type="bibr" rid="B4-kjim-27-221">4</xref>] and Yamazaki et al. [<xref ref-type="bibr" rid="B5-kjim-27-221">5</xref>] Information on these two published cases and our case is summarized in <xref ref-type="table" rid="T1-kjim-27-221">Table 1</xref>.</p><p>Vantyghem et al. [<xref ref-type="bibr" rid="B7-kjim-27-221">7</xref>] presented two cases of apa without hypertension; including these two cases, 18 cases of normotensive primary hyperaldosteronism have been reported. Only 10 of these cases have been published in the English literature, and about 75% of cases have been reported in Eurasians. Of the three cases listed in <xref ref-type="table" rid="T1-kjim-27-221">Table 1</xref>, one patient was Japanese, and another patient was Korean; no information was available regarding the third.</p><p>The normal blood pressure in these rare cases of primary aldosteronism is not fully understood, and various explanations have been offered, including an absence of volume expansion, a low-salt diet, abnormal atrial natriuretic peptide activity, and the use of glucocorticoids [<xref ref-type="bibr" rid="B7-kjim-27-221">7</xref>]. The patients might have been hypotensive before the onset of the disease, might have experienced a blunted response to pressor agents, or might have exhibited associated hypopituitarism [<xref ref-type="bibr" rid="B4-kjim-27-221">4</xref>]. The exact cause of this disease in our patient remains unknown.</p></sec></body><back><fn-group><fn fn-type="conflict"><p>No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ref-list><ref id="B1-kjim-27-221"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>A</given-names></name></person-group><article-title>Primary aldosteronism</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><fpage>1828</fpage><lpage>1834</lpage><pub-id pub-id-type="pmid">9854120</pub-id></element-citation></ref><ref id="B2-kjim-27-221"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>WF</given-names></name></person-group><article-title>Primary aldosteronism: renaissance of a syndrome</article-title><source>Clin Endocrinol (Oxf)</source><year>2007</year><volume>66</volume><fpage>607</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">17492946</pub-id></element-citation></ref><ref id="B3-kjim-27-221"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seccia</surname><given-names>TM</given-names></name><name><surname>Fassina</surname><given-names>A</given-names></name><name><surname>Nussdorfer</surname><given-names>GG</given-names></name><name><surname>Pessina</surname><given-names>AC</given-names></name><name><surname>Rossi</surname><given-names>GP</given-names></name></person-group><article-title>Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course</article-title><source>Endocr Relat Cancer</source><year>2005</year><volume>12</volume><fpage>149</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">15788646</pub-id></element-citation></ref><ref id="B4-kjim-27-221"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muthusethupathi</surname><given-names>MA</given-names></name><name><surname>Vimala</surname><given-names>A</given-names></name><name><surname>Jayakumar</surname><given-names>M</given-names></name><name><surname>Rajendran</surname><given-names>S</given-names></name></person-group><article-title>Normotensive primary aldosteronism due to adrenocortical carcinoma</article-title><source>Nephron</source><year>1998</year><volume>79</volume><fpage>247</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">9647521</pub-id></element-citation></ref><ref id="B5-kjim-27-221"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Katoh</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo</article-title><source>APMIS</source><year>1998</year><volume>106</volume><fpage>1056</fpage><lpage>1060</lpage><pub-id pub-id-type="pmid">9890267</pub-id></element-citation></ref><ref id="B6-kjim-27-221"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allolio</surname><given-names>B</given-names></name><name><surname>Fassnacht</surname><given-names>M</given-names></name></person-group><article-title>Clinical review: Adrenocortical carcinoma: clinical update</article-title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>2027</fpage><lpage>2037</lpage><pub-id pub-id-type="pmid">16551738</pub-id></element-citation></ref><ref id="B7-kjim-27-221"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vantyghem</surname><given-names>MC</given-names></name><name><surname>Ronci</surname><given-names>N</given-names></name><name><surname>Provost</surname><given-names>F</given-names></name><etal/></person-group><article-title>Aldosterone-producing adenoma without hypertension: a report of two cases</article-title><source>Eur J Endocrinol</source><year>1999</year><volume>141</volume><fpage>279</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">10474126</pub-id></element-citation></ref><ref id="B8-kjim-27-221"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>GL</given-names></name><name><surname>Turner</surname><given-names>ST</given-names></name></person-group><article-title>Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity</article-title><source>Clin Chem</source><year>2005</year><volume>51</volume><fpage>386</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">15681560</pub-id></element-citation></ref><ref id="B9-kjim-27-221"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JS</given-names></name><name><surname>Williams</surname><given-names>GH</given-names></name><name><surname>Raji</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia</article-title><source>J Hum Hypertens</source><year>2006</year><volume>20</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="pmid">16292348</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1-kjim-27-221" position="float"><label>Figure 1</label><caption><p>Abdominal computed tomography reveals a solid, homogenous 42 &#xD7; 33-mm adrenal mass (arrow).</p></caption><graphic xlink:href="kjim-27-221-g001"/></fig><fig id="F2-kjim-27-221" position="float"><label>Figure 2</label><caption><p>Histopathologically, the aldosterone-producing adrenocortical carcinoma shows solid nests of bland to anaplastic cells, with frequent mitoses and necrosis (H&amp;E, &#xD7; 400).</p></caption><graphic xlink:href="kjim-27-221-g002"/></fig><table-wrap id="T1-kjim-27-221" position="float"><label>Table 1</label><caption><p>Clinical features of the three cases of aldosterone-producing adrenocortical carcinoma without hypertension</p></caption><graphic xlink:href="kjim-27-221-i001"/><table-wrap-foot><fn><p>ND, not descriptive.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
